Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 222
Last updated 2015-10-02
Summary
Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.
Conditions
- Keratoconjunctivitis Sicca
Interventions
- DRUG
-
INS365 Ophthalmic Solution
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Primary Completion
- 2003-03-31
- Completion
- 2003-03-31
More Related Trials
-
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
NCT00667004 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
NCT03764735 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
NCT00198536 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
NCT01768312 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02254265 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
NCT06370039 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
NCT00001731 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients
NCT06337981 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
NCT02205840 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
NCT03237936 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
NCT06766357 ·Status: RECRUITING ·Phase: PHASE3
-
A Multi-Center Study Subjects With Dry Eye Syndrome
NCT01745887 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
NCT05411367 ·Status: COMPLETED ·Phase: PHASE3
-
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
NCT06360133 ·Status: RECRUITING ·Phase: PHASE3
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
NCT00370747 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3